Barcelona-based orthodontic chain Impress has successfully raised $117 million in a combination of equity and debt funding, aiming to bolster its services and reach in the European market. Specializing in invisible aligners, the company plans to utilize this capital to establish 20 new clinics by 2025 and to enhance access to high-quality orthodontic care. Impress’s growth has been notable in the orthodontics field, particularly following its acquisition of DrSmile from the Straumann Group. This move aligns with the company’s strategy to expand its digital and patient-centered care offerings, providing a wider range of technologically advanced orthodontic solutions.
Impress’s latest funding round was supported by major investors including Trinity Capital Inc, CareCapital, LBO France, and TA Ventures. Comparing this with past developments, Impress’s focus has consistently been on technological advancement and geographical expansion. Earlier, the company had adopted a similar strategy of growth through acquisitions and partnerships to enhance its market presence in various European countries. This funding round further accelerates its ongoing commitment to innovation and growth.
What Drives Impress’s Orthodontic Innovations?
Since its inception in 2019, Impress has been driven by a mission to innovate in orthodontic care. Co-founded by Dr. Khaled Kasem and entrepreneurs Diliara and Vladimir Lupenko, the company has been at the forefront of offering invisible aligners. These aligners cater to a diverse patient base across multiple countries including Spain, Italy, and the UK, leveraging AI-driven treatment planning and remote monitoring to enhance patient outcomes. Impress’s emphasis on digitalization and clinical excellence has solidified its position as the leading orthodontic chain in Europe, serving over 250,000 patients annually with a focus on delivering effective and medically supervised treatments.
Who Are the Investors Behind Impress’s Growth?
Trinity Capital, one of Impress’s key investors, is known for providing diversified financial solutions to growth-stage companies. Their investment strategy aims to generate income and capital appreciation through a mix of term loans, equipment financings, and equity-related investments. This backing from Trinity Capital and other investors underscores the confidence in Impress’s business model and future growth potential.
Impress’s continuous drive towards innovation is further articulated by Dr. Khaled Kasem, who emphasizes the importance of maintaining clinical oversight while adopting advanced technologies.
“This investment empowers us to build on our leadership in Europe and drive forward our vision of innovative, patient-centered orthodontic care,”
Kasem stated, highlighting the company’s commitment to broadening access to orthodontic treatments and enhancing patient experiences.
As the orthodontic landscape evolves, Impress remains focused on scaling its operations while maintaining quality and efficiency in care delivery. The company’s strategic initiatives not only aim at expanding physical locations but also emphasize strengthening technological capabilities to offer personalized and effective care solutions. This approach not only benefits Impress but also sets a benchmark for others in the industry.
The additional funding is set to propel Impress towards achieving its expansion and digital innovation objectives. With a clear strategy in place, the company is poised to further cement its role as a leader in providing advanced orthodontic solutions across Europe. As Impress continues to grow and adapt, it remains committed to delivering accessible and high-quality orthodontic care to an increasing number of patients.
